Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 06 - 28 symbols : Sny save search
Pharma, Research, And Medical Leaders Say Kidney Patients Are Key To Care Innovation
Published: 2021-06-28 (Crawled : 20:00) - prnewswire.com
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -1.03%
H: 0.28%
C: 0.08%
CDNA | $8.32 3.1% 3.0% 500K
|
Health Technology
|
| O: 0.18%
H: 1.68%
C: -0.61%
ARDX | $6.5 0.93% 0.92% 5.6M
|
Health Technology
|
| O: 0.5%
H: 0.31%
C: -1.88%
AKBA | $1.36 -2.16% -2.21% 2.9M
|
Health Technology
|
| O: 0.27%
H: 0.0%
C: -5.65%
research kidney pharma
AstraZeneca, Sanofi’s Monoclonal RSV Antibody Shows Promising Safety in Infants
Published: 2021-06-28 (Crawled : 19:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.34%
H: 0.47%
C: 0.24%
antibody
New Soliqua data shows improved blood sugar control without weight gain versus premixed insulin
Published: 2021-06-28 (Crawled : 18:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.34%
H: 0.47%
C: 0.24%
blood insulin
Clinical Catch-Up: June 21-25
Published: 2021-06-28 (Crawled : 17:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.34%
H: 0.47%
C: 0.24%
AGTC | $0.3936 1.23% 0.0%
|
Health Technology
|
| O: 1.7%
H: 0.48%
C: -3.58%
AVXL | News | $3.8 0.0% 2.1M
|
Health Technology
|
| O: 20.0%
H: 6.06%
C: -2.83%
The American Diabetes Association and Partners Commemorate 100th Anniversary of Discovery of Insulin and Look to the Next 100 Years for Breakthroughs Ahead
Published: 2021-06-28 (Crawled : 17:00) - prnewswire.com
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.34%
H: 0.47%
C: 0.24%
diabetes insulin
New Soliqua 100/33 data shows improved blood sugar control without weight gain versus premixed insulin
Published: 2021-06-28 (Crawled : 14:15) - prnewswire.com
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.34%
H: 0.47%
C: 0.24%
blood insulin
Lengo Therapeutics Appoints Enoch K. Kariuki as Chief Executive Officer
Published: 2021-06-28 (Crawled : 13:00) - biospace.com/
ZNTL | $12.97 3.43% 3.32% 1M
|
Health Technology
|
| O: 0.1%
H: 2.45%
C: -4.89%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.34%
H: 0.47%
C: 0.24%
therapeutics
Atsena Therapeutics Receives Orphan Drug Designation from the FDA for Novel Gene Therapy to Treat Genetic Eye Disease LCA1Phase I/II clinical trial is ongoing in patients with Leber congenital amaurosis caused by biallelic mutations in GUCY2D
Published: 2021-06-28 (Crawled : 13:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.34%
H: 0.47%
C: 0.24%
disease fda genetic ongoing eye gene therapy therapy eye disease drug trial gene therapies designation
Denali Therapeutics Announces Initiation of Phase 2 Study by Partner Sanofi of RIPK1-Inhibitor DNL758 (SAR443122) in Cutaneous Lupus Erythematosus (CLE) Patients
Published: 2021-06-28 (Crawled : 12:15) - globenewswire.com
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.34%
H: 0.47%
C: 0.24%
DNLI | $15.98 -3.74% -3.88% 1.5M
|
Health Technology
|
| O: 1.23%
H: 1.19%
C: -0.73%
phase 2 lupus
US Patient Perspective Survey of the Corporate Reputation of Pharma in 2020: Opinions of 207 US-based Patient Groups on the Performance of the Pharmaceutical Industry
Published: 2021-06-28 (Crawled : 11:00) - prnewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.14%
H: 0.38%
C: -0.26%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.34%
H: 0.47%
C: 0.24%
Kymera Therapeutics Announces Positive Interim Results from Single Ascending Dose Phase 1 Trial of KT-474 Demonstrating Degrader Proof-of-Mechanism
Published: 2021-06-28 (Crawled : 10:00) - globenewswire.com
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.34%
H: 0.47%
C: 0.24%
KYMR | $33.965 -3.29% -3.4% 630K
|
Health Technology
|
| O: 2.97%
H: 3.46%
C: 3.24%
phase 1 positive results trial phase 2
Nirsevimab shows positive topline results in RSV Phase 2/3 MEDLEY trial
Published: 2021-06-28 (Crawled : 08:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.34%
H: 0.47%
C: 0.24%
phase 2 phase 2/3 positive results topline trial
Dupixent® (dupilumab) SmPC Updated with Long-term Data Reinforcing Well-established Safety Profile in Adults with Moderate-to-severe Atopic Dermatitis
Published: 2021-06-28 (Crawled : 05:00) - prnewswire.com
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.34%
H: 0.47%
C: 0.24%
REGN | $896.27 0.26% 0.25% 500K
|
Health Technology
|
| O: 2.72%
H: 0.79%
C: -4.04%
dermatitis atopic dermatitis dupixent
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.